Effective treatment with ⍺1-protease inhibitor of chronic cutaneous vasculitis associated with ⍺1-antitrypsin deficiency - 12/09/11
Doi : 10.1016/0190-9622(95)90436-0
Sabrina K Dowd, MD a, George C Rodgers, MD b, Jeffrey P Callen, MD ⁎, a
a Division of Dermatology, University of Louisville School of Medicine, Louisville, Kentucky USA.
b Division of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky USA.
Reprint requests: Jeffrey P. Callen, MD, 310 E. Broadway #200, Louisville, KY 40202.Abstract |
The primary serum proteinase inhibitor is ⍺1-antitrypsin, and deficiency of this enzyme has been associated with a variety of systemic and cutaneous disorders. We report cutaneous vasculitis in a 49-year-old man with ⍺1-antitrypsin deficiency. His condition persisted despite treatment with colchicine, prednisone, and antibiotics but has been controlled by the administration of ⍺1-protease inhibitor.
Le texte complet de cet article est disponible en PDF.© 1995
Publié par Elsevier Masson SAS.
Vol 33 - N° 5P2
P. 913-916 - novembre 1995 Retour au numéro
Article précédent
- Genitourinary tumors in men with the Muir-Torre syndrome
- David A Davis, Philip R Cohen
- Improvement of eumycetoma with itraconazole
- Barry I Resnik, Anne E Burdick
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?